These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 26695395
1. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery. Rath E, Warschawski Y, Maman E, Dolkart O, Sharfman ZT, Salai M, Amar E. Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395 [Abstract] [Full Text] [Related]
3. The incidence of heterotopic ossification after hip arthroscopy. Bedi A, Zbeda RM, Bueno VF, Downie B, Dolan M, Kelly BT. Am J Sports Med; 2012 Apr; 40(4):854-63. PubMed ID: 22268230 [Abstract] [Full Text] [Related]
4. Postoperative nonsteroidal antiinflammatory drugs and the prevention of heterotopic ossification after cervical arthroplasty: analysis using CT and a minimum 2-year follow-up. Tu TH, Wu JC, Huang WC, Chang HK, Ko CC, Fay LY, Wu CL, Cheng H. J Neurosurg Spine; 2015 May; 22(5):447-53. PubMed ID: 25723121 [Abstract] [Full Text] [Related]
5. Efficacy of Nonsteroidal Anti-inflammatory Drug Prophylaxis for Heterotrophic Ossification in Hip Arthroscopy: A Systematic Review. Yeung M, Jamshidi S, Horner N, Simunovic N, Karlsson J, Ayeni OR. Arthroscopy; 2016 Mar; 32(3):519-25. PubMed ID: 26432432 [Abstract] [Full Text] [Related]
7. Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial. Beckmann JT, Wylie JD, Potter MQ, Maak TG, Greene TH, Aoki SK. J Bone Joint Surg Am; 2015 Dec 16; 97(24):2032-7. PubMed ID: 26677237 [Abstract] [Full Text] [Related]
8. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis. Zhu XT, Chen L, Lin JH. Medicine (Baltimore); 2018 Aug 16; 97(31):e11649. PubMed ID: 30075549 [Abstract] [Full Text] [Related]
9. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW. Acta Orthop; 2007 Feb 16; 78(1):90-4. PubMed ID: 17453398 [Abstract] [Full Text] [Related]
11. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach. White PB, Ramkumar PN, Meftah M, Ghazi N, Ranawat AS, Ranawat CS. Orthopedics; 2018 Jan 01; 41(1):e92-e97. PubMed ID: 29120007 [Abstract] [Full Text] [Related]
12. The Reduction of Heterotopic Ossification Incidence After Hip Arthroscopy in Patients Treated With Selective Cyclooxygenase 2 Inhibitor (Celecoxib). Dow T, King JP, Wong IH. Arthroscopy; 2020 Feb 01; 36(2):453-461. PubMed ID: 31734042 [Abstract] [Full Text] [Related]
19. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement. Pakos EE, Tsekeris PG, Paschos NK, Pitouli EJ, Motsis EK, Xenakis TA. J BUON; 2010 Feb 01; 15(1):74-8. PubMed ID: 20414931 [Abstract] [Full Text] [Related]
20. Incidence of heterotopic ossification in minimally invasive short-stem THA using the modified anterolateral approach. Kutzner KP, Hechtner M, Pfeil D, Rehbein P, Kovacevic MP, Schneider M, Siebert W, Pfeil J. Hip Int; 2017 Mar 31; 27(2):162-168. PubMed ID: 28218370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]